Blueberry Therapeutics Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 16

Employees
  • Latest Deal Type
  • Series B

  • Financing Rounds
  • 10

Blueberry Therapeutics General Information

Description

Developer of therapeutic drugs designed to help in the treatment of common dermatological disorders. The company's drugs are produced through a nano polymer drug delivery platform which formulates candidate drugs to enhance delivery into cells and tissue and to tackle the healthcare needs for patients with onychomycosis, tinea pedis, atopic dermatitis and other dermatological conditions, enabling patients to combat bacterial infection by neutralizing resistance in combination with standard antibiotics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Mereside, Alderley Park
  • Nether Alderley
  • Macclesfield SK10 4TG
  • England, United Kingdom
+44 01625 000000

Blueberry Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Blueberry Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Blueberry Therapeutics‘s full profile, request access.

Request a free trial

Blueberry Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutic drugs designed to help in the treatment of common dermatological disorders. The company's drugs
Drug Discovery
Macclesfield, United Kingdom
16 As of 2022
000.00
00.00 0000-00-00
00000000000 000.00

000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
000000000000000
Bromma, Sweden
0 As of 0000
000.00
000000 - 000 000.00

000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud ex
000000000000000
Laval, Canada
00000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Blueberry Therapeutics Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Moberg Pharma Corporation Bromma, Sweden 0 000.00 000000 - 000 000.00
000000 000000 0000 Corporate Backed or Acquired Laval, Canada 00000 000.00 000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Blueberry Therapeutics Patents

Blueberry Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210259981-A1 Compositions and methods of treatment Pending 03-Jul-2018 0000000000 0
GB-201810925-D0 Compositions and methods of treatment Inactive 03-Jul-2018 0000000000
EP-3817730-A1 Compositions and methods of treatment Pending 03-Jul-2018 0000000000
US-20200155482-A1 Nanoparticles formed of a polymer and terbinafine Pending 30-Jun-2017 0000000000
GB-201710491-D0 Composition and methods of treatment Inactive 30-Jun-2017 A61K31/135
To view Blueberry Therapeutics’s complete patent history, request access »

Blueberry Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
John Ridden Ph.D Co-Founder, Chief Executive Officer & Board Member
David Cook Ph.D Chief Scientific Officer
Mark Hollingworth Finance Director
Tony Sedgwick Ph.D Advisor to the Board
Liam Good Ph.D Scientific Advisor
You’re viewing 5 of 10 executive team members. Get the full list »

Blueberry Therapeutics Board Members (8)

Name Representing Role Since
000000 0000 00.0 Blueberry Therapeutics Board Member 000 0000
000000 000 Self Chairman 000 0000
000000000 0000 00.0 Self Board Member 000 0000
0000 000000 00.0 Blueberry Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
0000 00000000 00.0 Blueberry Therapeutics Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Blueberry Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Blueberry Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Blueberry Therapeutics‘s full profile, request access.

Request a free trial